JERUSALEM & LA JOLLA, Calif.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), today announced that they have entered into a ...
Auspex is developing SD-809, a deuterium substituted version of the established neurological drug tetrabenazine as a treatment for Huntington’s disease and other movement disorders. We believe ...
ALEXANDRIA, Va., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Edgesource Corporation, a small business delivering innovative solutions to the public sector, announced today that it has acquired Ashburn-based ...
Explore the Auspex Pharma stock price history with detailed daily historical prices, including open, high, low, close, and volume data. Review past trends, identify key price levels, and find the ...
This is a follow up article to my call in November 2014 to ' Buy Auspex Ahead of Phase 3 Data ' in December. On December 16, 2014, Auspex Pharmaceuticals, Inc. (NASDAQ: ASPX) announced positive ...
TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results